use
combin
virtual
screen
vs
highthroughput
screen
ht
techniqu
identifi
novel
nonpeptid
small
molecul
inhibitor
human
sarscov
structurebas
vs
approach
integr
dock
pharmacophor
base
method
employ
comput
screen
compound
zinc
librari
screen
protocol
valid
use
known
inhibitor
optim
speed
improv
select
accommod
receptor
flexibl
subsequ
fluorescencebas
enzymat
ht
assay
develop
optim
experiment
screen
approxim
compound
four
structur
divers
librari
chosen
mainli
base
vs
result
fals
posit
initi
ht
hit
elimin
secondari
orthogon
bind
analysi
use
surfac
plasmon
reson
spr
campaign
identifi
revers
small
molecul
inhibitor
exhibit
mixedtyp
inhibit
k
valu
togeth
result
valid
protocol
suitabl
approach
screen
virtual
chemic
librari
newli
identifi
compound
report
studi
repres
promis
structur
scaffold
pursu
sarscov
inhibitor
develop
highli
infecti
respiratori
ill
sever
acut
respiratori
syndrom
sar
emerg
southern
china
hong
kong
late
rapidli
spread
countri
infect
nearli
peopl
worldwid
mortal
rate
novel
human
coronaviru
sarscov
identifi
caus
agent
sar
although
contain
epidem
success
epidemiolog
quarantin
measur
possibl
reemerg
sarscov
sarslik
diseas
suggest
base
isol
close
relat
strain
horsesho
bat
two
new
human
coronavirus
name
identifi
sinc
turn
less
lethal
sarscov
howev
recent
identifi
human
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
infect
peopl
sinc
april
nearli
mortal
rate
death
report
number
keep
rise
daili
two
asian
bat
coronavirus
shown
closest
merscov
strongli
suggest
could
new
sarslik
new
strain
sar
human
coronavirus
could
caus
anoth
deadli
outbreak
futur
still
effect
therapi
sar
coronavir
infect
sar
coronaviru
gene
encod
two
overlap
polyprotein
process
viral
encod
peptidas
gener
function
viral
protein
sar
chymotrypsinlik
cystein
proteas
pro
primari
enzym
respons
proteolysi
cleav
initi
polyprotein
synthes
virion
eleven
fourteen
cleavag
site
due
crucial
role
matur
sarscov
pro
import
target
antisar
drug
design
pro
function
dimer
one
wall
activ
site
includ
loop
neighbor
monom
nterminu
one
monom
form
hydrogen
bond
adjac
monom
pocket
interact
two
monom
substanti
stabil
protein
behav
activ
dimer
monom
found
activ
form
howev
major
drug
discoveri
effort
sarscov
pro
report
date
employ
nonauthent
protein
ie
one
either
ntermin
gst
tag
ctermin
histag
crystal
structur
use
comput
studi
construct
use
enzym
assay
sinc
modifi
nand
ctermini
influenc
function
activ
sarscov
pro
inhibit
data
report
literatur
interpret
caution
sarscov
pro
target
extens
inhibitor
design
drug
design
strategi
rang
substratebas
peptidomimet
design
identif
lead
direct
highthroughput
screen
ht
comput
screen
larg
databas
mani
peptidomimet
inhibitor
pro
initi
develop
inhibitor
includ
warhead
moieti
form
coval
interact
catalyt
cystein
pro
develop
first
gener
coval
interact
peptidomimet
inhibitor
research
move
identifi
nonpeptid
small
molecul
inhibitor
also
larg
warheadbas
coval
bond
inhibitor
could
caus
unwant
problem
toxic
offtarget
side
effect
especi
cystein
proteas
thu
strong
need
identifi
novel
noncoval
inhibitor
enhanc
select
potenc
pro
work
describ
structurebas
virtual
screen
vs
subsequ
highthroughput
screen
ht
methodolog
identifi
novel
nonpeptid
noncoval
small
molecul
inhibitor
pro
human
sarscov
fig
lack
rigid
welldefin
deep
pocket
sarscov
pro
make
small
molecul
inhibitor
design
difficult
use
silico
approach
thu
develop
screen
protocol
use
tier
dock
dynam
pharmacophor
model
filter
screen
zinc
databas
fig
subsequ
develop
experiment
highthroughput
screen
assay
divers
small
molecul
four
chemic
librari
optim
orthogon
counterscreen
bind
assay
remov
fals
posit
fig
use
virtual
highthroughput
screen
present
sever
novel
chemic
scaffold
serv
excel
lead
candid
optim
biolog
activ
potenti
antisar
drug
design
virtual
screen
challeng
target
flexibilityth
sarscov
pro
bind
pocket
shown
quit
flexibl
previou
studi
base
crystal
structur
solv
variou
ph
valu
molecular
dynam
md
simul
nanosecondscal
md
simul
authent
sarscov
pro
dimer
structur
show
four
loop
surround
activ
site
region
sampl
altern
conform
fig
plot
figur
display
averag
perresidu
rmsd
ntermin
monom
rel
crystal
structur
signific
conform
flexibl
observ
activ
site
particularli
loop
constitut
wall
bind
pocket
flexibl
loop
expect
play
import
role
correct
posit
amino
acid
residu
substrat
bind
may
advers
affect
virtual
screen
perform
singl
rigidreceptor
dock
approach
often
undertaken
avail
apo
ligandbound
crystal
structur
sarscov
pro
elucid
structur
featur
enzym
substrat
bind
pocket
key
interact
import
molecular
recognit
allow
structurebas
screen
larg
compound
librari
success
dock
approach
reli
overal
classif
accuraci
score
function
well
earli
enrich
particularli
import
highthroughput
virtual
screen
examin
overal
predict
power
score
function
compound
valid
dataset
use
rank
order
correl
comput
dock
score
experiment
report
ic
valu
area
receiv
oper
characterist
roc
curv
auc
valu
see
method
correl
coeffici
auc
valu
assess
score
function
list
figur
found
surflexdock
gold
yield
poor
predict
accuraci
rescor
amberdock
improv
bind
free
energi
estim
dock
pose
gold
reduc
classif
accuraci
surflexdock
pose
initi
slope
roc
curv
quantifi
earli
enrich
score
function
found
amberdock
rescor
gold
bind
pose
goldscor
function
show
superior
earli
enrich
fig
result
show
amberdock
rescor
gold
bind
pose
display
best
predict
accuraci
term
earli
overal
enrich
pro
inhibitor
howev
remain
issu
use
amberdock
rescor
method
screen
larg
compound
librari
primarili
pose
refin
employ
energi
minim
molecular
dynam
bindingsit
residu
make
comput
slow
examin
tier
dock
consensu
score
along
dynam
pharmacophor
base
screen
approach
address
limit
molecular
dock
mention
tier
dock
approach
aim
increas
comput
effici
make
use
fast
dock
method
earli
stage
quickli
remov
nonbind
follow
use
rigor
accur
algorithm
promis
subset
rank
potenti
binder
consensu
score
method
combin
estim
differ
score
function
capit
strength
compens
error
individu
function
therebi
improv
hit
rate
dynam
pharmacophor
model
accommod
pro
activ
site
loop
flexibl
virtual
screen
tier
dockingsurflexdock
provid
good
compromis
overal
predict
power
character
auc
valu
valid
dataset
high
comput
speed
use
first
round
elimin
rapidli
discard
compound
fit
bind
pocket
pro
enzym
enrich
dataset
compound
could
form
favor
steric
electrostat
interact
enzym
activ
site
reduc
vernalislead
dataset
k
compound
k
compound
cleanlead
dataset
k
compound
k
compound
cluster
hit
surflexdock
gener
repres
set
structur
divers
compound
still
achiev
maximum
coverag
chemic
divers
space
reciproc
nearest
neighbor
rnn
pack
algorithm
use
gener
repres
set
compound
select
closest
neighbor
select
neighbor
least
similar
exhaust
search
repres
set
dock
gold
follow
rescor
dock
conform
gold
surflexdock
use
amberdock
evalu
sever
method
combin
rank
individu
score
function
improv
enrich
combin
predict
differ
model
gener
consensu
wide
employ
area
shown
robust
individu
compon
model
rational
behind
combin
rank
differ
score
function
may
differ
bias
may
sometim
wrongli
predict
bind
affin
compound
consensu
estim
multipl
score
function
potenti
approxim
true
activ
compound
evalu
consensu
score
method
perform
describ
supplementari
data
best
accuraci
enrich
obtain
ranksum
approach
sum
rank
goldscor
surflexdock
amberdock
rescor
gold
surflexdock
conform
method
retriev
maximum
activ
begin
order
list
also
show
significantli
higher
auc
score
function
fig
entir
repres
set
tier
dock
rank
use
ranksum
consensu
method
comput
solvent
map
csm
algorithm
determin
energet
favor
bind
posit
small
probe
activ
site
conserv
multipl
conform
protein
thu
make
gener
featur
independ
bind
site
conform
five
differ
probe
select
cover
common
function
group
found
inhibitor
molecul
well
offer
good
coverag
substraterecognit
pocket
pro
subsit
includ
residu
could
potenti
make
hydrogen
bond
interact
inhibitor
hydrophob
subsit
line
met
pro
asp
tyr
residu
methanol
acet
methylammonium
probe
use
identifi
hydrogen
bond
interact
benzen
probe
use
map
aromat
interact
ethan
probe
use
distinguish
hydrophob
interact
aromat
method
identifi
five
hot
spot
fig
aromat
featur
interact
subsit
two
aromatichydrophob
featur
subsit
acceptor
site
near
catalyt
cystein
donor
site
interact
residu
subsit
valid
gener
pharmacophor
model
ascertain
use
two
techniqu
water
molecul
use
probe
posit
consensu
cluster
compar
crystallograph
water
sarscov
pro
activ
site
method
reproduc
bind
site
three
bind
pocket
crystallograph
water
also
evalu
perform
gener
pharmacophor
model
valid
dataset
although
noninhibitor
close
resembl
activ
compound
chemic
structur
molecular
properti
model
differenti
well
two
class
model
correctli
predict
activ
compound
overal
accuraci
around
final
pharmacophor
queri
use
search
pregener
ligand
conform
repres
set
obtain
tier
dock
align
pharmacophor
coordin
gave
hit
rank
consensu
score
method
use
pick
top
score
commerci
avail
compound
pharmacophor
hit
priorit
compound
visual
inspect
elimin
reactiv
compound
effici
span
bind
site
final
compound
vernalislead
cleanlead
set
zinc
order
biolog
assay
sarscov
main
proteas
pro
exist
function
dimer
known
affin
tag
extra
amino
acid
residu
either
nterminu
cterminu
decreas
pro
enzym
activ
significantli
via
disturb
format
dimmer
henc
overexpress
purifi
authent
pro
without
addit
either
termini
current
dabcylktsavlqsgfrkmeedan
commerci
avail
fluoresc
reson
energi
transfer
fret
base
substrat
monitor
pro
enzym
activ
fluoresc
due
cleavag
edansdabcyl
substrat
monitor
excit
emiss
wavelength
nm
nm
addit
substrat
longwavelength
fluorophorequench
pair
alexa
fluorqsi
develop
compound
screen
monitor
excitationemiss
nm
nm
depend
type
alexa
fluor
qsi
typic
substrat
higher
wavelength
fluoresc
signal
work
better
ht
less
interfer
intrins
fluoresc
compound
reason
alexafluorqsi
would
better
substrat
edansdabcyl
howev
use
studi
primarili
due
much
greater
expens
instead
develop
new
pro
fret
substrat
peptid
label
fluorophor
quencher
qxl
studi
famqxl
pair
costeffect
altern
higher
excitationemiss
nm
wavelength
edansdabcyl
new
pro
substrat
nh
peptid
cleavag
sequenc
edansdabcylcontain
substrat
investig
new
famqxl
substrat
compar
kinet
paramet
edansdabcyl
summar
tabl
micha
constant
k
valu
famqxl
substrat
similar
edansdabcyl
howev
famqxl
substrat
exhibit
greater
k
cat
valu
edansdabcyl
substrat
result
higher
k
cat
k
famqxl
substrat
edansdabcyl
substrat
furthermor
inner
filter
effect
almost
develop
substrat
thu
success
develop
new
pro
substrat
good
enzym
effici
higher
wavelength
reduc
inner
filter
effect
ht
done
thorough
assay
optim
done
determin
optim
substrat
enzym
concentr
addit
reduc
agent
effect
dmso
toler
enzym
stabil
also
studi
order
determin
correct
substrat
concentr
ht
assay
micha
constant
k
determin
presenc
absenc
reduc
agent
describ
seri
dmso
concentr
rang
test
enzym
activ
substrat
stabil
less
inhibit
enzym
activ
observ
dmso
substrat
pro
show
sensit
dmso
start
therefor
final
dmso
concentr
less
use
assay
compound
select
vs
experiment
evalu
inhibitori
activ
sarscov
pro
use
new
famqxl
fretbas
substrat
total
virtual
screen
hit
purchas
initi
experiment
screen
conduct
singl
concentr
identifi
eight
compound
inhibit
ic
valu
activ
compound
determin
doserespons
curv
abl
obtain
ic
valu
six
compound
exhibit
micromolar
activ
potent
one
compound
show
ic
valu
slightli
less
fig
seven
analog
compound
identifi
zinc
evalu
howev
none
analog
found
inhibit
enzym
concentr
due
presenc
catalyt
cystein
pro
activ
site
hit
primari
screen
evalu
followup
assay
contain
reduc
glutathion
gsh
reduc
agent
elimin
coval
binder
maintain
protein
activ
state
eight
hit
identifi
preliminari
assay
four
compound
retain
ic
valu
micromolar
rang
fig
rest
lose
inhibitori
activ
presenc
gsh
ic
valu
four
hit
rang
presenc
gsh
none
analog
compound
found
inhibit
enzymat
activ
sarscov
pro
concentr
gsh
present
assay
buffer
base
vs
result
three
structur
divers
librari
inhous
collect
maybridg
divers
set
special
construct
antimicrobialantivir
focus
set
life
chemic
select
ht
compound
select
librari
exhibit
molecular
weight
distribut
basic
scaffold
similar
vs
hit
addit
prestwick
fdaapprov
drug
librari
also
screen
identifi
activ
known
drug
pro
togeth
total
compound
screen
pro
enzymat
endpoint
fluoresc
intens
assay
inhous
librari
includ
ten
control
compound
report
pubchem
highthroughput
screen
assay
mlpcn
compound
librari
sarscov
pro
primari
screen
done
duplic
vari
indic
high
qualiti
screen
campaign
replic
plot
percent
inhibit
shown
figur
also
illustr
good
qualiti
screen
primari
hit
percent
inhibit
greater
compound
concentr
cherrypick
retest
inhibitori
activ
continu
enzymat
assay
hand
compound
exhibit
ic
valu
less
reorder
commerci
vendor
activ
confirm
primari
screen
inhous
librari
identifi
three
hit
none
compound
show
ic
less
ten
compound
pubchem
exhibit
inhibitori
activ
similar
report
valu
pubchem
ic
valu
determin
one
pubchem
compound
shown
figur
primari
screen
prestwick
fdaapprov
drug
librari
result
one
hit
alexidin
dihydrochlorid
compound
fig
ic
valu
alexidin
dihydrochlorid
tyrosin
phosphatas
inhibitor
display
anticanc
activ
cell
also
kill
harm
germ
bacteria
often
use
cosmet
antisept
healthcar
product
primari
screen
maybridg
librari
result
hit
thirteen
compound
show
inhibit
ic
valu
reorder
nine
confirm
inhibitori
activ
five
compound
ic
valu
primari
screen
focus
life
chemic
librari
result
hit
eight
compound
show
ic
valu
reorder
six
ic
valu
three
compound
vari
fig
ht
hit
test
enzym
omiss
assay
elimin
fals
posit
caus
interfer
mediat
compound
fluoresc
rather
inhibit
pro
enzym
activ
compound
show
minor
interfer
hit
compound
show
effect
intens
fluoresc
signal
orthogon
bind
assay
surfac
plasmon
reson
spr
use
valid
hit
virtual
highthroughput
screen
addit
investig
inhibit
compound
deposit
pubchem
bioassay
databas
aid
sinc
knowledg
well
character
four
vs
hit
six
ht
hit
dissoci
equilibr
constant
k
five
compound
success
determin
calcul
k
valu
five
hit
rang
indic
direct
bind
pro
enzym
figur
show
k
curv
fit
one
identifi
hit
remain
compound
either
nonspecif
bound
enzym
bind
specif
shown
figur
compound
bind
pro
four
compound
exhibit
nonspecif
bind
pattern
fig
unfortun
drug
hit
alexidin
dihydrochlorid
prestwick
fdaapprov
drug
librari
also
turn
fals
posit
base
spr
bind
pro
enzym
therefor
consid
five
compound
worth
pursu
valid
revers
five
confirm
hit
compound
test
incub
pro
satur
concentr
inhibitor
concentr
respect
ic
valu
inhibit
pro
activ
compound
remov
desalt
column
pro
activ
monitor
determin
recoveri
rate
observ
recoveri
rate
pro
except
compound
show
consequ
four
compound
potenti
noncoval
revers
inhibitor
compound
new
scaffold
excel
lead
compound
optim
improv
potenc
although
remain
three
hit
show
similar
inhibitori
activ
pro
compound
better
candid
due
unattract
structur
compound
sequenti
elimin
primari
hit
followup
assay
summar
tabl
major
current
report
pro
inhibitor
competit
inhibitor
respect
substrat
investig
mechan
inhibit
compound
kinet
inhibit
compound
determin
pubchem
kinet
analysi
done
vari
concentr
substrat
enzymeinhibitor
complex
compound
differ
model
enzym
inhibit
competit
noncompetit
uncompetit
mixedtyp
fit
kinet
data
assess
use
michaelismenten
lineweaverburk
dixon
plot
use
sigmaplot
enzym
kinet
modul
best
fit
equat
lowest
akaik
inform
criterion
correct
aicc
valu
minimum
aicc
unit
differ
next
lowest
signific
compound
determin
competit
inhibitor
respect
substrat
k
valu
compound
show
mixedtyp
inhibit
differ
affin
free
pro
enzym
enzymesubstr
complex
k
valu
fig
determin
k
valu
similar
ic
valu
tabl
sinc
compound
competit
inhibitor
mixedtyp
inhibitor
appar
bind
activ
site
pro
appar
bind
site
distinct
activ
site
studi
bind
compound
sarscov
pro
molecular
dock
predict
bind
pose
key
interact
shown
fig
inhibitor
make
good
van
der
waal
contact
activ
site
span
mainli
subsit
block
access
catalyt
cystein
specif
inhibitor
make
hydrogen
bond
side
chain
hydroxyl
group
subsit
pchlorophenyl
moieti
inhibitor
make
hydrophob
contact
residu
subsit
newli
identifi
compound
small
compound
could
concern
nonspecif
thu
examin
select
compound
sarscov
pro
compound
test
three
proteas
name
sarscov
plpro
cystein
proteas
human
cystein
proteas
hepat
c
viru
serin
proteas
two
nonproteolyt
enzym
bacillu
anthraci
dihydroorotas
streptococcu
pneumonia
purc
compound
found
select
sarscov
cystein
proteas
show
inhibitori
activ
test
enzym
fig
compound
display
select
two
sar
cystein
proteas
pro
plpro
enzym
sinc
low
molecular
weight
compound
typic
lack
high
specif
inhibit
compound
enzym
especi
cystein
proteas
particularli
noteworthi
work
present
highthroughput
experiment
screen
approach
guid
structurebas
comput
method
discov
new
chemic
scaffold
develop
noncoval
inhibitor
sarscov
pro
identifi
two
compound
exhibit
ic
valu
low
micromolar
rang
unlik
major
pro
inhibitor
lead
report
date
either
contain
reactiv
warhead
may
potenti
engag
nonspecif
interact
cysteinecontain
protein
test
inhibitori
activ
presenc
reduc
agent
identifi
inhibitor
act
bind
revers
pro
function
presenc
physiolog
reduc
agent
gsh
studi
place
particular
emphasi
qualiti
result
step
screen
pipelin
rigor
experiment
valid
hit
virtual
screen
protocol
design
low
comput
complex
improv
enrich
abil
accommod
protein
flexibl
comput
screen
vs
hit
provid
insight
choos
appropri
compound
librari
ht
instead
screen
random
compound
librari
favor
bind
posit
small
probe
csm
studi
molecular
dock
studi
vs
hit
suggest
prefer
subsit
hydrophob
aromat
group
hydrogen
bond
interact
residu
subsit
accordingli
librari
select
enrich
aromat
group
hydrogen
bond
donor
acceptor
exhibit
molecular
size
distribut
similar
vs
hit
enzym
assay
ht
screen
employ
untag
construct
pro
enzym
new
fret
substrat
design
high
k
cat
k
valu
longer
excitationemiss
wavelength
minim
interfer
primari
hit
identifi
vs
ht
examin
bind
independ
spr
assay
follow
kinet
character
mode
compound
inhibit
identifi
hit
test
number
enzym
found
select
sarscov
proteas
enzym
togeth
result
indic
wellcharacter
hit
compound
identifi
studi
suffici
potent
provid
new
scaffold
develop
start
protein
conform
comput
taken
dimer
crystal
structur
pdb
code
residu
proton
match
low
ph
endosom
environ
proteolyt
process
believ
occur
valid
screen
protocol
carri
use
set
compound
identifi
literatur
test
experiment
pro
variou
research
group
tag
noncoval
inhibitor
ic
valu
activ
dataset
activ
inact
compound
use
two
subset
zinc
librari
vernalislead
compris
k
compound
cleanlead
compris
k
compound
virtual
screen
perform
molecular
dynam
md
simul
use
molecular
dynam
packag
forc
field
protein
structur
solvat
cubic
water
box
chlorid
ion
ad
neutral
system
period
boundari
condit
appli
nonbond
cutoff
system
first
subject
steepest
decent
energi
minim
follow
conjug
gradient
minim
system
heat
k
k
use
canon
nvt
ensembl
ps
final
ns
md
perform
k
trajectori
analyz
use
ptraj
modul
protein
structur
prepar
dock
calcul
done
use
tripo
inc
st
loui
mo
compar
perform
sever
dock
program
select
surflexdock
gold
studi
dock
pose
surflexdock
gold
use
input
amber
rescor
protocol
wherein
protein
residu
within
ligand
kept
flexibl
calcul
ranksum
vote
techniqu
consensu
score
investig
improv
enrich
compar
singl
score
function
see
supplementari
data
perform
dock
program
assess
valid
dataset
use
two
metric
rankord
correl
comput
dock
score
experiment
ic
valu
auc
roc
curv
describ
sensit
true
posit
rate
function
fals
posit
rate
vari
valu
threshold
compound
select
earli
enrich
assess
plot
compar
true
fals
posit
rate
low
threshold
auc
indic
overal
perform
classifi
compar
random
classif
auc
valu
would
correspond
random
classif
auc
valu
would
correspond
perfect
classif
dynam
structurebas
pharmacophor
model
gener
comput
solvent
map
csm
protocol
describ
briefli
fifteen
snapshot
last
nsmd
simul
bound
form
protein
ligand
remov
extract
base
activ
site
pocket
heavi
atom
rmsd
divers
compar
origin
crystal
structur
rmsd
frame
calcul
use
ptraj
modul
snapshot
cluster
use
kclust
program
mmtool
five
small
organ
molecul
probe
benzen
propan
methanol
acet
methylammonium
move
surfac
protein
activ
site
use
oper
mont
carlo
simul
anneal
algorithm
implement
autodock
dock
trial
probe
type
carri
follow
conform
cluster
final
dock
pose
best
score
molecul
autodock
determin
cluster
probe
type
retain
parent
molecul
cluster
align
parent
molecul
particular
probe
type
consensu
cluster
contain
least
parent
probe
form
center
point
cluster
comput
center
averag
parent
molecul
cluster
radiu
cluster
comput
averag
deviat
parent
probe
center
form
cluster
cluster
center
pharmacophor
model
built
use
molecular
oper
environ
moe
softwar
packag
v
chemic
comput
group
wwwchemcompcom
center
point
radiu
consensu
cluster
probe
type
residu
use
defin
center
point
exclud
volum
radiu
defin
boundari
pharmacophor
search
space
water
molecul
probe
also
dock
use
protocol
evalu
reproduct
crystallograph
water
site
stringenc
pharmacophor
model
examin
vari
requir
number
pharmacophor
element
must
match
enabl
partial
match
vari
radii
element
rulebas
torsion
drive
omega
openey
scientif
softwar
use
produc
multipl
conform
molecul
repres
set
use
energi
cutoff
kcalmol
calcul
mmff
forc
field
heavyatom
rmsd
criterion
pregener
conform
compar
pharmacophor
model
nativ
pro
gene
sarscov
polyprotein
residu
prepar
codonoptim
gene
synthesi
biobas
inc
clone
vector
bamhi
ecori
l
cell
grown
od
lb
medium
cell
induc
mm
iptg
hour
cell
harvest
lyse
sonic
lysi
buffer
mgml
lysozym
proteas
inhibitor
cocktail
buffer
mm
trishcl
ph
mm
nacl
mm
imidazol
mm
origin
construct
gsttag
nterminu
histag
cterminu
gsttag
autocleav
pro
upon
express
histag
fuse
pro
cterminu
purifi
histrap
hp
column
gradient
buffer
b
mm
trishcl
ph
mm
nacl
mm
imidazol
mm
pool
pro
dialyz
buffer
histag
cleav
unitsml
hrv
proteas
novagen
overnight
produc
pro
authent
c
terminu
final
pro
load
histrap
column
clean
hrv
proteas
cleav
histag
uncleav
histag
pro
nativ
sarscov
pro
purifi
size
exclus
column
chromatographi
buffer
contain
mm
trishcl
ph
mm
nacl
mm
dtt
mm
edta
glycerol
storag
new
fret
substrat
nh
design
synthes
anaspec
pro
activ
measur
continu
kinet
assay
substrat
commerci
avail
substrat
dabcylktsavlqsgfrkmeedan
micha
constant
k
valu
determin
substrat
final
assay
volum
assay
buffer
mm
hepe
ph
triton
mgml
bsa
mm
gsh
plate
corn
inc
seri
substrat
concentr
prepar
enzym
reaction
initi
ad
pro
nm
final
concentr
seri
substrat
concentr
without
enzym
also
measur
control
fluoresc
intens
nm
famqxl
nm
edansdabcyl
excitationemiss
monitor
continu
minut
polarstar
optima
micropl
reader
bmg
labtech
micha
constant
k
maxim
activ
v
max
calcul
fit
data
hyperbol
eq
initi
veloc
x
concentr
substrat
test
virtual
screen
hit
mm
solut
compound
chembridg
asinex
bioscreen
chemdiv
life
chemic
enamin
prepar
dmso
stock
solut
dilut
final
concentr
assay
buffer
contain
dmso
incub
nm
pro
min
reaction
initi
ad
final
concentr
famqxl
substrat
fluoresc
intens
measur
way
k
determin
use
inhous
librari
three
commerci
avail
compound
librari
ht
inhous
collect
includ
compound
three
librari
purchas
prestwick
maybridg
life
chemic
consist
compound
respect
compound
store
mm
stock
solut
dissolv
dmso
desicc
condit
primari
ht
assay
perform
tecan
freedom
evo
robot
equip
temo
liquid
handler
dispens
stainless
steel
pin
tool
v
p
scientif
nl
capillari
capac
assay
done
duplic
black
plate
matrix
technolog
room
temperatur
pro
enzym
nm
final
concentr
prepar
assay
buffer
mm
hepe
ph
triton
mgml
bsa
mm
gsh
enzym
solut
dispens
well
nl
mm
compound
final
concentr
ad
incub
min
enzym
reaction
initi
substrat
final
concentr
dissolv
assay
buffer
incub
min
follow
ad
sd
stop
solut
fluoresc
intens
monitor
tecan
genio
pro
micropl
reader
plate
contain
total
posit
neg
control
hit
compound
ht
cherrypick
reanalyz
continu
kinet
assay
hand
confirm
show
inhibit
confirm
assay
ic
valu
measur
use
assay
condit
primari
screen
hand
triplic
seri
compound
concentr
final
concentr
serial
dilut
dmso
prepar
plate
enzym
solut
distribut
well
vari
concentr
compound
ad
incub
min
enzym
reaction
initi
ad
substrat
activ
continu
monitor
min
ic
valu
calcul
fit
hill
eq
use
originpro
originlab
inc
percent
inhibit
x
inhibitor
concentr
n
slope
concentrationrespons
curv
hill
slope
v
max
maxim
inhibit
two
four
independ
assay
enzym
omiss
assay
done
exactli
method
ic
determin
without
pro
enzym
order
test
fluoresc
signal
interfer
test
compound
nativ
pro
enzym
prepar
pb
mm
phosphat
ph
mm
kcl
mm
nacl
immobil
sensor
chip
use
standard
aminecoupl
run
buffer
hbsp
mm
hepe
mm
nacl
surfact
ph
use
biacor
instrument
flow
channel
activ
carbodiimid
hydrocholorid
edc
nhydroxi
succinimid
nh
mixtur
activ
surfac
block
ethanolamin
ph
control
pro
enzym
dilut
mm
sodium
acet
ph
immobil
flow
channel
sensor
surfac
activ
edcnh
follow
ethanolamin
block
unoccupi
surfac
area
pro
immobil
level
flow
channel
ru
ru
respect
unrel
refer
protein
kda
also
immobil
flow
channel
anoth
control
compar
pro
kda
monom
six
initi
ht
hit
one
vs
hit
prepar
mm
dmso
stock
solut
compound
solut
seri
increas
concentr
dilut
appli
four
channel
flow
rate
sensorgram
analyz
use
biaevalu
softwar
respons
unit
differ
valu
concentr
measur
equilibr
phase
data
either
singl
referenc
blank
enthanolamin
doubl
referenc
blank
refer
protein
ru
valu
sigmaplot
use
fit
data
singl
rectangular
hyperbol
curv
determin
k
valu
hyperbol
function
max
k
x
use
plot
respons
unit
correspond
concentr
respons
max
maximum
respons
x
compound
concentr
nm
pro
incub
screen
compound
concentr
ic
compound
h
room
temperatur
assay
buffer
contain
mm
hepe
ph
mm
gsh
mgml
bsa
triton
dmso
final
volum
control
pro
without
compound
also
prepar
way
sampl
includ
posit
control
without
compound
buffer
exchang
assay
buffer
desalt
column
pierc
remov
compound
pro
activ
measur
way
ic
measur
buffer
exchang
pro
activ
monitor
way
primari
screen
vari
concentr
inhibitor
compound
substrat
concentr
compound
vari
least
ic
valu
fragment
data
fit
follow
equat
use
sigmaplot
enzym
kinet
modul
order
determin
best
fit
inhibit
mechan
kinet
paramet
compound
reaction
rate
v
max
maximum
rate
reaction
k
michaelismenten
constant
substrat
substrat
concentr
inhibitor
concentr
k
dissoci
constant
inhibitor
free
enzym
dissoci
constant
inhibitor
es
complex
pharmacophor
model
gener
use
comput
solvent
map
pharmacophor
featur
shown
within
pro
activ
site
aromat
aro
affin
site
green
hbond
donor
site
red
hbond
acceptor
acc
site
blue
aromatichydrophob
arohydro
site
turquois
exclud
volum
region
grey
kinet
inhibit
pro
activ
compound
dixon
plot
competit
inhibit
compound
mix
inhibit
b
compound
respect
substrat
nh
determin
k
valu
respect
four
equat
see
method
sigmaplot
enzym
kinet
modul
use
fit
experiment
data
competit
inhibit
model
best
fit
mix
inhibit
model
c
final
hit
rate
calcul
number
compound
order
experiment
test
one
